HemoTypeSC Has a CE Mark and is Registered in Nigeria and Kenya

ASH Conference News Stories

Subheading

"$2 Test Could Transform Sickle Cell Dx in Africa"

December 13, 2018

" 'HemoTypeSC is an accurate, inexpensive, and rapid tool that can enable sickle cell disease screening programs across rural areas of Africa and India, where it's not being screened for at all,' - late-breaking abstract press briefing at the American Society of Hematology meeting."

Read More

"New Sickle Cell Test Can Transform Screening"

December 13, 2018

  
 "A new test that costs less than $2, requires only a small drop of blood, and can be performed in about 10 minutes could dramatically change the dynamics of sickle cell diagnosis in Africa, say researchers who developed the product."
Read More

HemoTypeSC Presented in Late-Breaking Abstract

December 13, 2018

"A trial in Uganda showed a new test called HemoTypeSCTM was more than 99 percent accurate in detecting sickle cell disease in young children. The test requires only a small drop of blood and returns results in about 10 minutes, making it suitable for routine screening of newborns."
Read More